|
Real-time Estimate
Cboe Europe
09:05:41 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 12,080.00 GBX | -0.54% |
|
+1.10% | -12.24% |
| 08:13am | AstraZeneca: Share price weakness of late, should be capitalised on |  |
| 09-03 | UK stocks rise as bond rally lifts risk sentiment | RE |
| Market Cap | 255B 219B 206B 188B 352B 24,107B 354B 2,436B 949B 12,320B 958B 937B 39,677B | P/E 2026 * |
21.1x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 274B 236B 222B 203B 378B 25,947B 381B 2,622B 1,021B 13,260B 1,031B 1,008B 42,705B | EV / Sales 2026 * |
4.34x | EV / Sales 2027 * | 3.99x |
| Free-Float |
96.63% | Yield 2026 * |
2.03% | Yield 2027 * | 2.17% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Tradegate
| ZEG | Real-time | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
CBOE
| AZN | Real-time | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript : AstraZeneca PLC
| 1 day | -0.40% | ||
| 1 week | +0.97% | ||
| Current month | +0.97% | ||
| 1 month | +2.95% | ||
| 3 months | -10.83% | ||
| 6 months | -19.90% | ||
| Current year | -12.36% |
| 1 week | 11,650 |  | 12,290 |
| 1 month | 11,404 | | 12,476 |
| Current year | 10,524 | | 15,732 |
| 1 year | 10,524 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,029 | | 15,732 |
| 10 years | 3,996 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Jeffrey Pott
CMP | Compliance Officer | - | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/17/26 | Exercice | Chief Financial Officer | 11,133 | 0.0007% | ||
| 8/6/26 | Free | SVP, Group Controller | 2 | 0.0000% | - | |
| 7/6/26 | Free | See Remarks | 2 | 0.0000% | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.40% | +0.97% | -0.84% | +13.06% | 255B | |
| -0.04% | -1.40% | +57.16% | +108.15% | 1,034B | |
| +1.17% | +4.76% | +56.42% | +73.50% | 671B | |
| -0.58% | +0.80% | +22.82% | +75.58% | 460B | |
| -0.58% | -1.06% | +28.73% | +37.75% | 353B | |
| -1.13% | +4.93% | +24.94% | +45.84% | 309B | |
| +0.29% | +1.63% | +56.46% | +73.00% | 240B | |
| -0.37% | +1.54% | -16.77% | -54.22% | 207B | |
| +1.08% | +1.59% | +33.83% | +97.29% | 188B | |
| -0.72% | +2.82% | +16.22% | -19.48% | 164B | |
| Average | -0.41% | +1.43% | +27.90% | +45.05% | 388.1B | |
| Weighted average by Cap. | -0.48% | +1.12% | +37.15% | +63.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.25B 54.42B 51.07B 46.72B 87.21B 5,979B 87.9B 604B 235B 3,055B 238B 232B 9,841B | 66.85B 57.52B 53.98B 49.39B 92.18B 6,320B 92.91B 639B 249B 3,230B 251B 246B 10,401B |
| Net income | 12.02B 10.34B 9.7B 8.88B 16.57B 1,136B 16.7B 115B 44.7B 581B 45.13B 44.15B 1,870B | 13.7B 11.79B 11.06B 10.12B 18.89B 1,295B 19.04B 131B 50.96B 662B 51.45B 50.33B 2,132B |
| Net Debt | 19.46B 16.75B 15.71B 14.38B 26.83B 1,840B 27.05B 186B 72.39B 940B 73.08B 71.49B 3,028B | 11.79B 10.14B 9.52B 8.71B 16.25B 1,114B 16.38B 113B 43.85B 569B 44.27B 43.3B 1,834B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | GBX 12,097.55 | -0.40% | 334,808 |
| 26-09-03 | GBX 12,146.00 | +1.42% | 2,394,368 |
| 26-09-02 | GBX 11,976.00 | +0.12% | 2,766,205 |
| 26-09-01 | GBX 11,962.00 | -0.07% | 2,914,975 |
| 26-08-28 | GBX 11,970.00 | -1.19% | 3,627,957 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
